A previous study revealed that the level of LC3B, which is an important marker of autophagosome formation, was elevated in an Aβ-treated AD model in SH-SY5Y cells when lncRNA17A was knocked down compared with that in cells with elevated expression of lncRNA17A. Here, MAP1LC3B is linked to Alzheimer disease.